Renalytix Plc
RENXF
$0.02
-$0.01-35.66%
OTC PK
| 12/31/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 9.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 9.53% | |||
| Cost of Revenue | 0.00% | -8.49% | |||
| Gross Profit | 0.00% | 154.55% | |||
| SG&A Expenses | 0.00% | 16.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -8.39% | |||
| Operating Income | 0.00% | 9.96% | |||
| Income Before Tax | 0.00% | 8.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 8.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 8.64% | |||
| EBIT | 0.00% | 9.96% | |||
| EBITDA | -- | 10.02% | |||
| EPS Basic | 0.00% | 35.44% | |||
| Normalized Basic EPS | 0.00% | 35.73% | |||
| EPS Diluted | 0.00% | 36.00% | |||
| Normalized Diluted EPS | 0.00% | 35.73% | |||
| Average Basic Shares Outstanding | 0.00% | 41.48% | |||
| Average Diluted Shares Outstanding | 0.00% | 41.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||